Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1472-1474 (28 June), doi:10.1136/bmj.39590.732037.47
Paul Glasziou, professor of evidence based medicine1, Emma Meats, research assistant1, Carl Heneghan, senior clinical research fellow1, Sasha Shepperd, NIHR research scientist in evidence synthesis 2
1 Centre for Evidence-Based Medicine, Department of Primary Health Care, University of Oxford, Oxford OX3 7LF, 2 Department of Public Health, University of Oxford
Correspondence to: P Glasziou paul.glasziou@dphpc.ox.ac.uk
Replicating non-pharmacological treatments in practice depends on how well they have been described in research studies
| The first 150 words of the full text of this article appear below. |
Have you ever read a trial or review and wondered exactly how to carry out treatments such as a "behavioural intervention," "salt reduction," or "exercise programme"? Although CONSORT and related initiatives have focused on the assessment of validity and presentation of results,1 2 less attention has been given to the adequacy of the description of the treatment used. For pharmacological treatments the description would need to include the dose, titration, route, timing, duration, and any monitoring used. For complex treatments the problems are even greater.
The uptake of positive findings from trials is often slow and sometimes negligible.3 Reasons for this slow uptake include clinicians not becoming aware of the results, perceiving the results as either invalid or not relevant to their patients, or simply not remembering to use the treatment.4 5 An additional barrier, which has received less attention, is clinicians ability to carry out the treatment on the basis of
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.